General Psychiatry
RSS
Psychiatric Illness in the Elderly
Dan G. Blazer, PhD, MD
Vice Chair, Department of Psychiatry and Behavioral Sciences, Vice Chair, Academic Development, Duke University
Dr. Blazer has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Read More
Antipsychotics and Anticonvulsants for Anxiety Disorders
Steve Balt, MD, MS
Board Member, The Carlat Report. In private practice in the San Francisco Bay area.
Dr. Balt discloses that his spouse is employed as a sales representative for Otsuka America.
Read More
Table - FDA Approved Medications for Anxiety
Steve Balt, MD, MS
Board Member, The Carlat Report. In private practice in the San Francisco Bay area.
Dr. Balt discloses that his spouse is employed as a sales representative for Otsuka America.
Read More
EXPERT Q&A
Anxiety Disorders in DSM-5 and Beyond
Daniel Pine, MD
Chief, Section on Development and Affective Neuroscience, National Institute of Mental Health, Chair, DSM-5 Work Group on Child and Adolescent Psychiatric Disorders Dr. Pine has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
Carlat Total Access Subscriptions: Get access to every article on the website.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
Recommended
